EOLS · Evolus, Inc.

Revenue grew 6.7% year-over-year to $73.1 million in Q1 FY2026, building on U.S. product momentum and international expansion amid evolving market dynamics. This top-line progress supported gross profit expansion to $48.9 million, maintaining a 66.9% gross margin. Management notes that cost of goods sold anticipates fluctuations from changes in product and geographical mix, as well as current and threatened tariffs, which introduce variability even as volumes rise.

The standout operational achievement was the 54.9% reduction in operating loss to -$6.8 million from -$15.2 million a year ago. This improvement stemmed directly from strategic cost structure optimization initiatives that lowered operating expenses, as highlighted in Management's Discussion. These efforts narrowed the operating margin gap to -9.4%, positioning the company closer to breakeven by addressing expense inefficiencies without compromising growth investments. Net income followed suit, improving 43.5% to -$10.7 million, with diluted EPS advancing to -$0.16 from -$0.30, reflecting disciplined resource allocation.

Liquidity remains anchored by the Revolving Credit Facility, which matures March 3, 2029, and carries a $10.0 million minimum utilization requirement. This provides a buffer for meeting obligations through operating cash flows and capital management, though variable interest rates introduce market-linked costs. Selling, general, and administrative expenses may fluctuate with marketing strategies, new product launches, and international expansion, balancing growth ambitions with cost discipline. Prior losses and expected future losses highlight the need for continued execution to support stock value and capital access, as noted in risk factors.